CYTK – cytokinetics, incorporated (US:NASDAQ)
Stock Stats
News
Cytokinetics Announces Recipients of Its Eighth Annual Communications Grant Program
Cytokinetics, Incorporated (CYTK): A Bull Case Theory [Yahoo! Finance]
Cytokinetics (NASDAQ:CYTK) had its price target raised by analysts at Truist Financial Corporation from $84.00 to $92.00. They now have a "buy" rating on the stock.
Cytokinetics' heart drug hits market after FDA approval [FOX Business Network]
Cytokinetics (NASDAQ:CYTK) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $87.00 price target on the stock.
Form 4 CYTOKINETICS INC For: Feb 05 Filed by: Callos Andrew
Form 4 CYTOKINETICS INC For: Feb 02 Filed by: Callos Andrew
Form 4 CYTOKINETICS INC For: Jan 15 Filed by: Daly James M
Form 4 CYTOKINETICS INC For: Jan 15 Filed by: Wysenski Nancy
Form 4 CYTOKINETICS INC For: Jan 15 Filed by: WIERENGA WENDELL
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.